ENG

  • Jim QIU

    Equity Partner / Shanghai

  • Tel +86-21-6061-3666

    Email jimqiu@zhonglun.com

  • Practices

    Compliance & Investigation, Investment/M&A & Corporate Governance, Private Equity & Investment Funds

  • Industries

    Pharmaceuticals & Life Sciences, Healthcare, Telecom & Information

CV

Jim QIU

Mr. Jim Qiu specializes in corporate compliance within the life sciences and healthcare sphere. He provides comprehensive compliance and risk management services to a diverse range of corporate clients. Leveraging an extensive track record, he advises on corporate compliance management and operations, the analysis, control, and mitigation of compliance risks, compliance reviews, compliance investigations, and due diligence. Furthermore, he offers strategic counsel and support for domestic and cross-border regulatory proceedings and compliance-related litigation.

Mr. Qiu serves as long-term legal counsel to numerous multinational and domestic Fortune 500 companies operating across the pharmaceutical, medical device, pharmaceutical services, and digital health sectors. His practice covers the entire lifecycle of healthcare and life sciences businesses, encompassing market access and regulatory supervision, licensing transactions, product R&D and clinical trial compliance, general healthcare regulatory compliance, product marketing, academic activities, healthcare professional (HCP) interactions, pharmacovigilance, medical device adverse events, digital health, medical e-commerce, and doctor-patient dispute resolution. Beyond the core healthcare sector, Mr. Qiu and his team possess substantial expertise in advising on health foods, cosmetics, foods for special medical purposes (FSMP), infant formula, and pet foods (including prescription pet diets).

Alongside his legal practice, Mr. Qiu serves as the Director of Professional Committee of Pharmaceutical and Healthcare Affairs of Shanghai Bar Association. He also acts as long-term external legal counsel to major medical associations and organizations in Shanghai, including the Shanghai Medical Association, and is a featured columnist for the Compliance Section of LexisNexis, a leading global publisher.

Representative Matters

Compliance and Regulation in Medical Healthcare Industry

  • Provided retainer-based general legal and compliance services to Sanofi for its China operations, covering both day-to-day matters and specific projects

  • Advised Merck Sharp & Dohme on a retainer basis regarding its China operations, covering general corporate and compliance matters

  • Provided retainer-based general legal services to the R&D division of BeiGene

  • Provided legal services, including regulatory compliance advice, to Roche regarding its digital marketing business

  • Assisted United Imaging with day-to-day compliance affairs and contract management

  • Provided retainer-based general legal and compliance services to Stryker in connection with its daily operations

  • Provided retainer-based general legal advice to Smith & Nephew regarding day-to-day compliance affairs

  • Provided retainer-based general legal services to Hoya/Pentax for its China operations, covering both day-to-day compliance and specific projects

  • Provided retainer-based general legal and compliance services to the healthcare division of ByteDance

  • Provided retainer-based general legal and compliance services to the Tencent Healthcare Affairs Division

  • Provided retainer-based general legal and compliance services to DXY regarding its China operations

  • Provided comprehensive, retainer-based general legal services to the Joint Administration Office of Shanghai Medical Organizations (including the Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, and Shanghai Nursing Association)

  • Assisted a U.S.-based global pharmaceutical company on a retainer basis in managing nationwide adverse event cases

  • Represented a U.S.-based pharmaceutical company in a product liability and drug quality dispute arising from adverse drug reactions

  • Represented a multinational pharmaceutical company in an indemnification dispute lawsuit involving subjects of multi-center clinical trials

  • Provided targeted compliance advice to a multinational pharmaceutical company regarding bid evaluation matters for the centralized volume-based procurement (VBP) of medicines

  • Provided targeted compliance advice to a renowned Israeli medical device company on the China market entry pathway for an innovative drug-device combination product

  • Represented a European multinational pharmaceutical company in leading a nationwide anti-corruption investigation into alleged bribery and enhancing its China compliance program

  • Advised a U.S.-based multinational medical device company on nationwide commercial bribery investigations


Compliance in Other Sectors

  • Represented Anheuser-Busch InBev in conducting compliance reviews and due diligence for multiple acquisition transactions in China

  • Assisted Anheuser-Busch InBev on a retainer basis with routine compliance reviews of new vendors

  • Advised listed company Luyang Energy-Saving Materials Co., Ltd. on a retainer basis regarding comprehensive compliance and risk management for its China operations

  • Assisted numerous U.S. and European multinational companies with internal anti-bribery investigations and the enhancement of compliance programs for their China operations

  • Advised numerous U.S. and European multinational companies on potential compliance risks associated with their China-based distribution networks and sales incentive programs

  • Provided anti-corruption and anti-bribery training to numerous multinational and domestic companies, advising on compliance remediation programs for their China operations

  • Provided nationwide legal support to numerous U.S. and European multinational companies in responding to government investigations across various compliance matters

  • Assisted several prominent U.S. and European manufacturing corporations in executing nationwide anti-counterfeiting enforcement programs

  • Advised a European multinational pharmaceutical company on responding to nationwide government investigations regarding alleged unfair competition violations

  • Represented a prominent European cosmetics company in a government investigation and subsequent compliance remediation program following a major safety incident

  • Represented a prominent U.S.-based chemical company in a government investigation regarding potential environmental violations

Honors and Awards

For Individual

Ranked in the healthcare sector, Chambers Greater China Region Legal Guide, 2023-2025

Outstanding Writer (Compliance Sector), LexisNexis, 2021

Recommended in healthcare and life sciences sector, Legal 500 Asia-Pacific, 2020-2024

China 100 A-list lawyers, China Business Law Journal, 2016

Memberships & Affiliations

Member, China Law Society and Shanghai Law Society

Director, Professional Committee of Pharmaceutical and Healthcare Affairs, Shanghai Bar Association

Member, Life Sciences Law Committee, Shanghai Law Society

Member, Competition Law Committee, Shanghai Law Society

Legal Counsel and Deputy Director, Legal Affairs Center, Shanghai Medical Ethics Association

Legal Counsel, Joint Administration Office of Shanghai Medical Organizations (the umbrella organization for the Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, Shanghai Nursing Association, etc.)

Columnist, Compliance Section, LexisNexis

Expert Consultant for Civil and Administrative Cases, Supreme People's Procuratorate

Legal Counsel to the Songjiang District People's Government, Shanghai

Specially Invited Mediator, Professional People's Mediation Center of Pudong New Area, Shanghai

Publications

"Research and Proposal on Medical Expenses Bearing System During Major Epidemics" (awarded in the essay competition held by Healthcare Legal Service Special Group of the All China Lawyers Association)

"Legitimate Handling of Medical Expenses During the Pandemic", official website of the Shanghai Bar Association (included in the Compilation of Studies on Legal Issues Against the Pandemic in the Field of Medicine and Healthcare by the Medical and Health Committee of the Shanghai Bar Association)

"Supervision and Legal Risks Regarding Online Diagnosis and Treatment", LexisNexis (also included in The Great Health Industry: Policy, Trends, and Legal Innovations published by Law Press China)

"Updates for You: New Rules for Online Diagnosis and Hospital Management", Wolters Kluwer

"Compliance Manual for Anti-Commercial Bribery Practices", LexisNexis

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar
    PRC Certified M&A Dealmaker

  • Education

    LL.M., University of Minnesota Law School, Minnesota, US
    LL.B., East China University of Political Science and Law, Shanghai, China

  • Professional Experience

    Partner, Zhong Lun Law Firm

  • Languages

    Chinese
    English